Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Colour Doppler Flow Imaging in Lacrimal Gland Lesions (GLIR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02900846
Recruitment Status : Completed
First Posted : September 14, 2016
Last Update Posted : January 31, 2017
Sponsor:
Information provided by (Responsible Party):
Fondation Ophtalmologique Adolphe de Rothschild

Brief Summary:
Retrospective medical charts and medical imaging files review of patients suffering from lacrimal fossa lesions who underwent ocular ultrasonography with color flow doppler imaging.

Condition or disease
Lacrimal Tumor

Layout table for study information
Study Type : Observational
Actual Enrollment : 51 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Usefulness of Colour Doppler Flow Imaging in the Management of Lacrimal Gland Lesions
Study Start Date : January 2003
Actual Primary Completion Date : December 2015
Actual Study Completion Date : August 2016



Primary Outcome Measures :
  1. Pulsed wave doppler resistance index in tumor vascularization [ Time Frame: 1 week ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients suffering from lacrimal fossa tumors explored with ultrasonography including doppler flow imaging
Criteria

Inclusion Criteria:

  • Patients suffering from lacrimal fossa tumor
  • Orbital ultrasonography performed, including doppler flow imaging
  • Histopathological characterization of the tumor obtained after surgical removal

Exclusion Criteria:

  • Absence of histopathological characterization
  • Absence of documented ultrasound doppler flow imaging

Layout table for additonal information
Responsible Party: Fondation Ophtalmologique Adolphe de Rothschild
ClinicalTrials.gov Identifier: NCT02900846     History of Changes
Other Study ID Numbers: NI_ALR_2015_1
First Posted: September 14, 2016    Key Record Dates
Last Update Posted: January 31, 2017
Last Verified: January 2017